Vaccine Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Vaccine Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Bacillus Calmette-Guerin Vaccines
Study findings from D. Dilli et al broaden understanding of Bacillus calmette-guerin vaccines
May 7th, 2008
In this recently published article, scientists in Ankara, Turkey conducted a study "To determine whether age at bacilli Calmette-Gurin (BCG) and hepatitis B vaccination has an effect on the development of atopy and allergic disorders in early childhood. This was a cross-sectional study of 109 children aged between 24 and 36 months with respiratory system diseases." "The study population was divided into two groups according to vaccination regimens: group 1, beginning hepatitis B vaccination at birth and receiving BCG vaccine at two months of age; group 2, receiving BCG vaccine at birth and beginning hepatitis B vaccination at two months of age. Atopic status was...
Source: Vaccine Weekly (2008-05-07)
|
